HomeBXP • LON
add
Beximco Pharmaceuticals GDR
Previous close
GBX 42.50
Day range
GBX 45.00 - GBX 45.00
Year range
GBX 31.55 - GBX 52.33
Avg Volume
79.27K
P/E ratio
-
Dividend yield
-
Financials
Income Statement
Revenue
Net income
| (BDT) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 12.30B | 12.80% |
Operating expense | 3.17B | 15.07% |
Net income | 1.83B | 27.65% |
Net profit margin | 14.88 | 13.16% |
Earnings per share | — | — |
EBITDA | 2.91B | 10.59% |
Effective tax rate | 23.11% | — |
Balance Sheet
Total assets
Total liabilities
| (BDT) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.85B | 64.65% |
Total assets | 73.80B | 4.50% |
Total liabilities | 20.17B | -6.53% |
Total equity | 53.63B | — |
Shares outstanding | 446.11M | — |
Price to book | 0.00 | — |
Return on assets | 8.29% | — |
Return on capital | 10.14% | — |
Cash Flow
Net change in cash
| (BDT) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.83B | 27.65% |
Cash from operations | 1.04B | -41.02% |
Cash from investing | -1.56B | -159.63% |
Cash from financing | 1.32B | 231.32% |
Net change in cash | 795.91M | 423.84% |
Free cash flow | 1.09B | -52.99% |
About
Founded
1976
Headquarters
Website
Employees
1,122
